in Canada through Endo's subsidiary Paladin Pharma Inc. "We look forward to working with MC2 to make Wynzora ® Cream available to Canadians who suffer from plaque psoriasis," said Livio Di ...
"If approved by Health Canada, Wynzora® Cream's unique formulation and clinical profile will offer patients a new treatment option designed for convenience of use in daily routines." "Paladin has ...
announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora ® Cream (calcipotriene and betamethasone dipropionate) in Canada through Endo's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results